SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-008438
Filing Date
2022-03-31
Accepted
2022-03-31 16:06:59
Documents
84
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2165767
2 ex10-22.htm EX-10.22 200790
3 ex10-22a.htm EX-10.22A 40007
4 ex10-30c.htm EX-10.30C 51164
5 ex10-31b.htm EX-10.31B 45173
6 ex10-32b.htm EX-10.32B 45728
7 ex21-1.htm EX-21.1 4223
8 ex23-1.htm EX-23.1 3903
9 ex31-1.htm EX-31.1 18149
10 ex31-2.htm EX-31.2 18225
11 ex32-1.htm EX-32.1 7569
12 ex32-2.htm EX-32.2 7525
13 form10-k_003.jpg GRAPHIC 40174
  Complete submission text file 0001493152-22-008438.txt   8714106

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE ensc-20211231.xsd EX-101.SCH 54857
15 XBRL CALCULATION FILE ensc-20211231_cal.xml EX-101.CAL 70210
16 XBRL DEFINITION FILE ensc-20211231_def.xml EX-101.DEF 267502
17 XBRL LABEL FILE ensc-20211231_lab.xml EX-101.LAB 477640
18 XBRL PRESENTATION FILE ensc-20211231_pre.xml EX-101.PRE 383863
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1073939
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38306 | Film No.: 22792466
SIC: 2834 Pharmaceutical Preparations